This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Pfizer's stock underperformed its healthcare peers since PFE topped out in late July 2024. Click here to find out why I ...

We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

Research organisations Biowaived, Matheus Engineering and Particology Ltd have all been created by former Pfizer staff. Their ...

Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% ...

In comparison, at its current levels of around $195, AbbVie stock trades at 18x expected 2024 earnings of $10.88 per share. This compares with the 12x average P/E multiple for ABBV seen over the last ...

Pfizer Singapore announced that the Health Sciences Authority has approved the company’s Abryvso vaccine for respiratory ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...